Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 15;11(1):829–840. doi: 10.1080/22221751.2022.2048969

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 6. — Different composite pattern between booster vaccination and breakthrough infection. (a) Neutralizing antibody titre against Wuhan-1 stain for samples collected at D14 post booster vaccinations and D14 post breakthrough infection. n = 20 in I-I-I, n = 10 in I-I-S, n = 16 in recovered Delta breakthrough patients. (b, c) The portion of neutralizing antibody titre compared to total anti-S + N and anti-RBD antibody at 1M post two-dose vaccination, post booster vaccinations and post breakthrough infection. n = 20 in I-I, n = 13 in I-I-I, n = 23 in I-I-S, n = 11 in Delta-Recovery. (d, e) The portion of neutralizing antibodies represented by monoclonal antibody 13G2 or 08B3 compared to total neutralizing antibody for vaccination samples and breakthrough infection samples. n = 13 in I-I-I, n = 23 in I-I-S, n = 11 in Delta-Recovery. ns, not significant; *P < 0.05, ***P < 0.001, ****P < 0.0001.